You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Ethicon
Metabolic Disease & Obesity
Ethicon
Metabolic Disease & Obesity
As one of the world’s largest healthcare companies and a major supplier and partner of the NHS, we are determined in our mission to improve access to appropriate treatment for people living with obesity. We intend to establish meaningful partnerships with the NHS & Government to drive support and awareness, empowering more patients to access appropriate treatment for Obesity including Metabolic Surgery in line with NICE guidelines.
IMAGES
rgb(200,16,46)
Obesity and Covid-19
Evidence suggests that individuals living with obesity who catch Covid-19 are...
113%
more likely to be hospitalised.1
74%
more likely to be admitted to the intensive care unit.1
48%
more likely to die.1
How we can help
Research & Evidence
Continue to support research that aims to clarify the best possible treatment with people living with severe and complex obesity taking into account changes in the environment including pandemics like covid.2
Education & Training
Aiming to provide not only surgical professional education on current and emerging techniques, but education that enhances the patient experience and benefits the whole healthcare system.
Access to Treatment
Helping to improve access to treatment for people living with obesity in the UK through our unique initiatives. Contact us to learn more about what we’re doing in this space!
Meaningful Partnerships
We partner with our customers in a meaningful way to improve metabolic pathways and support the restart of services, acceleration of recovery and expansion to tackle waiting lists and ensure access to appropriate treatments.
Contact us to learn more about how partnering with Ethicon Metabolic can help you to identify areas for improvement across metabolic pathways and implement solutions which support your Trust’s objectives.
Bariatric Surgery
Ethicon is committed to shaping the future of treatment for people living with obesity including surgery through research and evidence, best-in-class professional education and expanding access to treatment.
Reality of Obesity Campaign
Almost two-thirds of UK adults are considered overweight or obese; with approximately 1 in 4 people living with obesity. Despite the high prevalence, obesity is misunderstood and there is a need to improve education around obesity.3 The Reality of Obesity campaign is committed to changing this narrative through improved understanding of both obesity itself and the societal factors that may affect or contribute.
Helpful Links
Bariatric Surgery
Services & Solutions Team
Ethicon Home
Ethicon Customer Support
References
1. Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, Alsukait RF, Alluhidan M, Alazemi N, Shekar M. Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships. Obesity Reviews. 2020 Nov;21(11):e13128.
2. Galvain T, Patel S, Kabiri M, Tien S, Casali G, Pournaras DJ. Cost effectiveness of bariatric and metabolic surgery, and implications of COVID 19 in the United Kingdom. Surg Obes Relat Dis. 2021 Nov;17(11):1897 1904.
3. Baker, C, Obesity Statistics Briefing Paper, House of Commons Library, 2021, p4-5. https://researchbriefings.files.parliament.uk/documents/SN03336/SN03336.pdf. Accessed 3 September 2021.
211712-220503 UK